CD8A and neoplasm: As part of an iterative approach, the validated model and associated predictions suggest that increasing the number of tumor infiltrating CD8+ T cells was necessary but not sufficient for CD8+ T cell-mediated control of tumor growth and outgrowth of B16F10 tumors depended on a transient loss of MHC class I antigen presentation.